Antiviral agents. 1-Aralkyloxyadenosines.
D000241:Adenosine / Q000138:chemical synthesis* / Q000494:pharmacology; D000256:Adenoviridae / Q000187:drug effects; D000818:Animals; D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D002277:Carcinoma; D002460:Cell Line; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D004285:Dogs; D004987:Ethers / Q000138:chemical synthesis / Q000494:pharmacology; D006564:Herpesviridae / Q000187:drug effects; D006801:Humans; D007668:Kidney; D009062:Mouth Neoplasms; D009975:Orthomyxoviridae / Q000187:drug effects; D018108:Respirovirus / Q000187:drug effects; D012229:Rhinovirus / Q000187:drug effects; D013329:Structure-Activity Relationship; D014616:Vaccinia virus / Q000187:drug effects
D000998:Antiviral Agents; D004987:Ethers; D000241:Adenosine